Navigation Links
Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease

CAMBRIDGE, Mass., April 16, 2007 /PRNewswire-FirstCall/ -- Genzyme Corp. announced today that a recently completed study of Renvela(TM) (sevelamer carbonate) achieved its primary endpoint, demonstrating a statistically significant reduction in serum phosphorus for hyperphosphatemic patients with chronic kidney disease who are not on dialysis.

Patients treated with Renvela also achieved a significant reduction in calcium-phosphorus product and in LDL cholesterol. The drug was well tolerated with a safety profile consistent with the clinical experience of patients on dialysis using Renagel(R) (sevelamer hydrochloride). The multi-center, single arm, open-label trial involved 49 patients at multiple study sites throughout Europe and Australia.

Full data will be presented at a future medical conference.

Renvela is a buffered form of Renagel, the most-prescribed phosphate binder in the United States. Like Renagel, Renvela is a calcium-free, metal- free, non-absorbed phosphate binder and will initially be available as 800mg tablets once approved.

The results announced today represent one portion of a comprehensive clinical program for sevelamer carbonate. Data showing the equivalence of sevelamer carbonate and sevelamer hydrochloride were presented last week at the spring clinical meeting of the National Kidney Foundation. In addition, enrollment is complete in two studies comparing a powder form of sevelamer carbonate to Renagel tablets dosed three times per day, including one study in which the powder form is dosed three times per day, and one in which it is dosed once per day.

A New Drug Application for Renvela is currently under review by the US Food and Drug Administration for the control of serum phosphorus in patients with chronic kidney disease on dialysis.

About Renagel

Renagel controls serum phosphorus in patients with CKD on hemodialysis. Controlling serum ph
'"/>




Page: 1 2 3

Related medicine technology :

1. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
2. Genzyme Announces Results of Clinical Trial of Hylastan
3. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
4. Genzyme Announces Results of Clinical Trials Investigating Powder Form of Sevelamer Carbonate
5. Genzyme and Bayer HealthCare Announce Detailed Interim Two-Year Alemtuzumab in Multiple Sclerosis Data Presented at AAN
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:7/25/2014)... , July 25, 2014 /PRNewswire-iReach/ -- "Australia Capsule Endoscopy ... on the Australia Capsule Endoscopy Systems market. The report ... units) and average prices (in US dollars) within market ... , Capsule Endoscopes , Capsule Endoscopy ... The report also provides company shares and distribution ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- ScriptPro, of ... Powers Lake, Wisconsin , announce ... distribution and co-marketing agreement allowing ScriptPro to bring ... the United States . ScriptPro ... and workflow systems to retail and ambulatory pharmacies. ...
(Date:7/25/2014)... , July 25, 2014 GrowBLOX Sciences, Inc. (OTCQB: ... Memorandum of Understanding ("MOU") with LaurelCo, LLC, an ... acquisition of both cultivation and dispensary medical marijuana licenses in ... the MOU, GBLX will acquire a 20% equity interest in ... GrowBLOX TM growing chambers, as well as all technology ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3
(Date:7/25/2014)... 2014 Deep Research Report ... Industry” is a professional and in-depth research ... Permeation Chromatography market. The report provides basic ... Chromatography definition, classification, application, and industry chain ... research covers the international market analysis, including ...
(Date:7/25/2014)... TX (PRWEB) July 26, 2014 ... Laser Scanning Confocal Microscope Industry” is a ... Laser Scanning Confocal Microscope market. The report ... including Laser Scanning Confocal Microscope definition, classification, ... industry overview. This research covers international market analysis, ...
(Date:7/25/2014)... In recent years, men have become more aware of, ... associated with age-related testosterone decline. Amid concerns about testosterone and ... case study from Renew Man helps to shed light ... bioidentical hormones. , The case study centers around a patient ... beginning to feel the effects of age-related hormonal decline. ...
(Date:7/25/2014)... July 26, 2014 According to ... Market by Product (vibration monitoring, thermography, ultrasound emission, ... analysis), Component, Application and Geography - Global Forecast ... machine health monitoring market is expected to reach ... to 2020. , Browse 117 market data Tables ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 American motor ... or unexpected collisions can pay higher premiums for vehicle ... its local insurer network to provide SR22 insurance for ... , The different coverage network of local agencies ... expanded the search platform now publicly available for any ...
Breaking Medicine News(10 mins):Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 2Health News:2014 China & Global GPC Industry - Gel Permeation Chromatography Development Trends Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 2Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 3Health News:Laser Scanning Confocal Microscope Market: 2014 Global, China Manufacturing Bases Analysis Now at DeepResearchReports.com 4Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 2Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 3Health News:Machine Health Monitoring Market by Product, Component & Application Worth $2.50 Billion by 2020 - New Report by MarketsandMarkets 4Health News:SR22 Insurance for High Risk Motorists Added to Local Quotes System at Insurer Website Online 2
... PHILADELPHIA Researchers have made an important step ... autism spectrum disorders. A researcher collaboration, including geneticists ... and The Children,s Hospital of Philadelphia (CHOP), have ... responsible for neurological development, learning and memory, which ...
... As part of Jani-King International, a worldwide leader in ... to fight swine flu influenza A (H1N1) in schools, ... that the number of reported cases in the United ... from trips to Mexico, many schools have shut down ...
... School explains how and why the swine flu virus is threatening humans ... , ... Boston, MA (Vocus) April 28, 2009 -- A new report from ... threatening humans and describes what to do if the infection reaches your ...
... Barnes of Greenway Medical Technologies and Chairman of HIMSS Electronic Health ... Proper Guidelines for Meaningful EHR UseCARROLLTON, Ga., April 28 ... , A total ... will address key aspects of certified electronic health record (EHR) ...
... FRANCISCO, April 28 DIAKADI Body, Personal ... kick off its summer outdoor workout series, the hottest and ... the month of June, individuals of all fitness levels will ... to take on the DIAKADI way of training! The outdoor ...
... provider of healthcare on-demand patient and staff education, healthcare televisions ... Hospital East, in Louisville, KY. , ... ... -- TeleHealth Services , the nation,s leading provider of ...
Cached Medicine News:Health News:Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism 2Health News:Jani-King of Cleveland Ready to Fight Swine Flu 2Health News:Harvard Medical School Releases Special Health Report on Swine Flu 2Health News:Health IT Experts Assemble in Washington D.C. to Present Testimony on Definition of Meaningful Use Before National Committee on Vital and Health Statistics (NCVHS) 2Health News:Health IT Experts Assemble in Washington D.C. to Present Testimony on Definition of Meaningful Use Before National Committee on Vital and Health Statistics (NCVHS) 3Health News:Health IT Experts Assemble in Washington D.C. to Present Testimony on Definition of Meaningful Use Before National Committee on Vital and Health Statistics (NCVHS) 4Health News:SF Outdoor Workout Series: Definitely Not Your Typical Boot Camp! 2Health News:SF Outdoor Workout Series: Definitely Not Your Typical Boot Camp! 3Health News:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 2Health News:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 3Health News:TeleHealth Services Chosen by Baptist Hospital East in Development of New Park Tower 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: